Clinical trial

500mg Fulvestrant Versus Exemestane in MBC

NCT03575260

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-07-01

PhaseN/A

Study timeline

Study start (actual)2017-07-01Date precision: day

Registry last updated2019-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03575260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.